Sentences with phrase «pharmacogenomics company»

I continued working at the interface of science and epidemiology, first with Genaissance Pharmaceuticals, a New Haven - based pharmacogenomics company, where I was involved in the fascinating study of human genetic variation and population genetics.

But as the Mason, Ohio - based pharmacogenomics company mushroomed from one table to three offices, it became harder to keep a handle on the company culture.

Not exact matches

We also describe how pharmaceutical companies practice genomics and outline the experiences of two professionals in the pharmacogenomics field.

For aspiring geneticists, the lesson of the two companies» transformations is that genetics is moving into the realm of the practical, with the promise of personalized medicine and pharmacogenomics.

«Young companies trying to get into pharmacogenomics and personalized medicine are facing daunting challenges because of uncertainties with FDA and just the inherent difficulties of trying to change the paradigm to something where side effects are unacceptable,» says Galas.

From the very first collaborations with companies doing pharmacogenomic analyses on new drugs, he has had to abide by strict agreements of confidentiality.

Drug companies were much in evidence at the convention, and if there is one area of genomics that has attracted a critical mass of believers, it's pharmacogenomics.

Previous experience also includes a role as Senior Scientist with Eli Lilly and Company where she was part of the Pharmacogenomics and Translational Medicine Group in charge of discovering and validating genetic / genomic biomarkers in different therapeutic areas (oncology, cardio - metabolic and neurosciences).

Professor George Patrinos (University of Patras, Greece) gave an update on the use of whole genome sequencing in pharmacogenomics, which followed by several company lectures that supported the event as sponsors.

Proponents of personalized medicine were thankful for several developments that show this trend is picking up speed: CVS followed Medco's example in expanding pharmacogenomic testing, while biotech and pharma companies, as well as the National Cancer Institute, stepped up their investment in the field.